NRl 566/l NR566l Finall Exam:l Advancedl
Pharmacologyl forl Carel ofl thel Familyl
Guidel (Latestl 2026/l 2027l Update)l |l Qsl
&l As|l Gradel A|l 100%l Correctl (Verifiedl
Answers)-l Chamberlain
QUESTION
MAOIsl MOA
Answer:
-MAO:l enzymel inl liver,l intestinall wall,l &l terminalsl ofl neuronsl
-MAOl convertsl NE,l 5-HT,l &l dopaminel intol inactivel productsl
-MAOIs:l inhibitl MAOl inl nervel terminals-->l increasingl thel NEl &l 5HTl available
QUESTION
bipolarl longl terml preventativel tx
Answer:
-moodl stabilizerl preventl recurrencel ofl maniacl &l depressivel episodes
QUESTION
TCAl contraindications
Answer:
-promotesl mania,l notl recommendedl forl BPD
QUESTION
acutel managementl ofl severel mania
,Answer:
-lithiuml
-valproate
QUESTION
lithiuml adversel effects
Answer:
-<1.5mEq/L:l tremor,l GIl upset,l thirst,l musclel weakness;l
-1.5-2mEq/L:l confusion,l hyperirritabilityl ofl muscles,l ECGl changes,l sedationl
-2-2.5mEq/L:l ataxia,l tinnitus,l sz,l HOTN,l coma,l death
QUESTION
lithiuml adversel effectl management
Answer:
-monitorl levelsl Q2-3l daysl atl first-->l Q3-6monthl @l maintenance
-HD
QUESTION
insomnia
Answer:
-1stl choice:l benzosl (decreasesl latencyl timel tol falll asleep,l awakenings,l andl sleepingl
time)
QUESTION
buspironel action
Answer:
-usedl forl anxiety
-bindsl tol serotonin
,QUESTION
amphetaminesl cardiovascularl effects
Answer:
-increasesl HR,l atrioventricularl conductions,l forcel contraction,l HTN
QUESTION
preventionl ofl amphetaminel w/drawl
Answer:
-avoidl rapidl w/drawl
QUESTION
amphetaminesl peripherall actions
Answer:
-vasoconstriction
QUESTION
amphetaminesl therapeuticl uses
Answer:
ADHD,l narcolepsy
QUESTION
drugl interactionl w/l MAOIsl &l SSRIs
Answer:
-contraindicated
-increasesl riskl ofl serotoninl syndromel
-MAOIsl effectsl lastl longl afterl dosingl stops
-waitl 14l daysl afterl stoppingl MAOIsl beforel startingl SSrIs
, QUESTION
SSRIl sidel effectl management
Answer:
-avoidl abruptl cessationl
-reportl selfl harm/l SI
QUESTION
neurotransmittersl affectedl byl SNRIs
Answer:
-blockl thel serotoninl andl norepinephrine
QUESTION
SNRIsl andl SSRIl comparison
Answer:
-equall butl SSRIsl arel saferl &l betterl tolerated
QUESTION
Venlafaxinel discontinuation
Answer:
abruptl d/c-->l w/drawll syndromel (anxiety,l agitation,l tremors,l h/a,l vertigo,l tachy,l tinnitus)
QUESTION
venlafaxinel sidel effectsl management
Answer:
QUESTION
Pharmacologyl forl Carel ofl thel Familyl
Guidel (Latestl 2026/l 2027l Update)l |l Qsl
&l As|l Gradel A|l 100%l Correctl (Verifiedl
Answers)-l Chamberlain
QUESTION
MAOIsl MOA
Answer:
-MAO:l enzymel inl liver,l intestinall wall,l &l terminalsl ofl neuronsl
-MAOl convertsl NE,l 5-HT,l &l dopaminel intol inactivel productsl
-MAOIs:l inhibitl MAOl inl nervel terminals-->l increasingl thel NEl &l 5HTl available
QUESTION
bipolarl longl terml preventativel tx
Answer:
-moodl stabilizerl preventl recurrencel ofl maniacl &l depressivel episodes
QUESTION
TCAl contraindications
Answer:
-promotesl mania,l notl recommendedl forl BPD
QUESTION
acutel managementl ofl severel mania
,Answer:
-lithiuml
-valproate
QUESTION
lithiuml adversel effects
Answer:
-<1.5mEq/L:l tremor,l GIl upset,l thirst,l musclel weakness;l
-1.5-2mEq/L:l confusion,l hyperirritabilityl ofl muscles,l ECGl changes,l sedationl
-2-2.5mEq/L:l ataxia,l tinnitus,l sz,l HOTN,l coma,l death
QUESTION
lithiuml adversel effectl management
Answer:
-monitorl levelsl Q2-3l daysl atl first-->l Q3-6monthl @l maintenance
-HD
QUESTION
insomnia
Answer:
-1stl choice:l benzosl (decreasesl latencyl timel tol falll asleep,l awakenings,l andl sleepingl
time)
QUESTION
buspironel action
Answer:
-usedl forl anxiety
-bindsl tol serotonin
,QUESTION
amphetaminesl cardiovascularl effects
Answer:
-increasesl HR,l atrioventricularl conductions,l forcel contraction,l HTN
QUESTION
preventionl ofl amphetaminel w/drawl
Answer:
-avoidl rapidl w/drawl
QUESTION
amphetaminesl peripherall actions
Answer:
-vasoconstriction
QUESTION
amphetaminesl therapeuticl uses
Answer:
ADHD,l narcolepsy
QUESTION
drugl interactionl w/l MAOIsl &l SSRIs
Answer:
-contraindicated
-increasesl riskl ofl serotoninl syndromel
-MAOIsl effectsl lastl longl afterl dosingl stops
-waitl 14l daysl afterl stoppingl MAOIsl beforel startingl SSrIs
, QUESTION
SSRIl sidel effectl management
Answer:
-avoidl abruptl cessationl
-reportl selfl harm/l SI
QUESTION
neurotransmittersl affectedl byl SNRIs
Answer:
-blockl thel serotoninl andl norepinephrine
QUESTION
SNRIsl andl SSRIl comparison
Answer:
-equall butl SSRIsl arel saferl &l betterl tolerated
QUESTION
Venlafaxinel discontinuation
Answer:
abruptl d/c-->l w/drawll syndromel (anxiety,l agitation,l tremors,l h/a,l vertigo,l tachy,l tinnitus)
QUESTION
venlafaxinel sidel effectsl management
Answer:
QUESTION